VaccinesFlu vaccine for children — what do vaccine critics say?
Sources: 7 · Article: 7 290 characters
The STOP NOP Association claims that a study of children was supposed to show 5.5 times more cases of respiratory illness after vaccination than after placebo.
- According to the association, vaccine effectiveness during the 2012/2013 season ranged from 9 to 56 percent, depending on the strain, and vaccination does not always prevent infection.
- Jerzy Zięba claims that the vaccine was given to adults and children without clinical trials demonstrating its effectiveness and safety.
What the authors write
Stowarzyszenie STOP NOP
A study of children was supposed to show 5.5 times more cases of respiratory illness after vaccination than in the placebo group.
„Researchers conducted a double-blind, placebo-controlled study in children using a trivalent inactivated influenza vaccine. Their results were published in the journal Clinical Infectious Diseases in 2012, and it turned out that the seasonal influenza vaccine caused 5.5 times more cases of respiratory illness than in the placebo group.”Naukowcy przeprowadzili badanie z podwójnie ślepą próbą z placebo na dzieciach z trójwartościową inaktywowaną szczepionką przeciwko grypie. Ich wyniki zostały opublikowane w czasopiśmie Clinical Infectious Diseases w 2012 r. i okazało się, że szczepionka przeciw sezonowej grypie spowodowała 5,5 razy więcej przypadków choroby układu oddechowego niż w grupie placebo.
Stowarzyszenie STOP NOP
Vaccine effectiveness during the 2012/2013 season ranged from 9 to 56 percent, depending on the strain, and vaccination does not always prevent infection.
„Influenza vaccine: Limited effectiveness
Unfortunately, some people may become infected with a strain of influenza virus that the influenza vaccine is intended to protect against, even after vaccination. The protection provided by the influenza vaccine may vary, depending in part on the health and age of the person vaccinated.”Szczepionka przeciwko grypie: Ograniczona skuteczność
?Niestety niektórzy mogą zakazić się szczepem wirusa grypy przeciwko któremu szczepionka przeciwko grypie ma chronić nawet pomimo szczepienia. Ochrona zapewniona przez szczepionkę przeciwko grypie może być różna, w zależności częściowo od stanu zdrowia i wieku osoby szczepionej.?
Jerzy Zięba
The influenza vaccine was supposed to be given to adults and children without clinical trials demonstrating its effectiveness and safety.
„The influenza vaccine is a drug being introduced into the bodies of Polish adults and children without any clinical trial, not even the smallest one. It is the only “drug” (after all, it does not cure anything) that does not require its effectiveness or, most importantly, its safety to be demonstrated.”Szczepionka przeciw grypie jest właśnie lekiem wprowadzanym do organizmu Polaków dorosłych i dzieci bez żadnego badania klinicznego, nawet najmniejszego. Jest to jedyny „lek” (niczego przecież nie leczy), który nie wymaga wykazania jego skuteczności ani, co najważniejsze, jego bezpieczeństwa.
Stowarzyszenie STOP NOP
Vaccine effectiveness during the 2012/2013 season was said to range from 9 to 56 percent, depending on the strain.
„Centers for Disease Control (2013)42
According to the CDC, influenza vaccine effectiveness during the 2012/2013 season ranged from 9 to 56 percent, depending on the strain, while older people had little or no immunity against the influenza A H3N2 strain.43 Flu symptoms: There are two main types of influenza (A and B). Symptoms include fever, chills, sore throat, fatigue, muscle and body aches, cough, diarrhea, and vomiting, and can last for more than a week.”Centers for Diseases Control (2013)42
Według CDC, skuteczność szczepionki przeciwko grypie w sezonie 2012/2013 wynosiła od 9 do 56 procent, w zależności od szczepu, przy czym osoby starsze uzyskiwały słabą odporność przeciwko szczepowi grypy A H3N2, lub nie miały jej wcale.43Objawy grypy: Istnieją dwa główne rodzaje grypy (A i B), których objawy obejmują gorączkę, dreszcze, ból gardła, zmęczenie, ból mięśni i ciała, kaszel, biegunkę i wymioty, które mogą utrzymywać się nawet ponad tydzień.
Research from PubMed · Europe PMC
We selected 1 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 9 747.
The vaccine reduced the overall risk of influenza, but protection weakened during part of the period, and vaccination in two consecutive seasons was associated with lower effectiveness in the current season.
Aim of the study: To comprehensively evaluate the real-world effectiveness of the influenza vaccine among school-aged children across a dual-peak season, specifically examining subtype-specific protection, age variations, durability of protection over time, and the impact of repeated prior-season vaccination.
Results: Among 1669 eligible participants (463 cases and 1206 test-negative controls), the overall adjusted VE against medically attended influenza was 46.36% (95% CI: 29.23-59.34%). VE differed across age groups and was mainly observed in younger children. Significant protection was observed within 14-119 days post-vaccination, became non-significant during 120-239 days, and re-emerged during the summer peak at 240-299 days. Prior-season vaccination alone provided no significant residual protection, while repeated vaccination across two consecutive seasons was associated with reduced effectiveness in the current season. Subtype-specific VE was 43.48% (95% CI: 18.00-61.04%) against influenza A(H1N1), 34.42% (95% CI: 0.55-56.76%) against influenza A(H3N2), and 56.95% (95% CI: 7.68-79.93%) against the B/Victoria lineage. During the winter-spring peak, VE was 49.84% (95% CI: 26.90-65.59%).
Money for the studygovernment, public institutions · Beijing Natural Science Foundation, Sanming Project of Medicine in Shenzhen, National Key Research and Development Program of China
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyobservation of people
Participants1 669
“Not stated” does not mean nobody paid — the database does not always record it.
Perspectives and opinion materials
The content below presents the authors’ opinions, interpretations and hypotheses. It is not treated as equal to scientific studies and systematic reviews.
Orthomolecular Medicine News Service Opinion material
„One review of ten RCTs found an efficacy of 59% for adults aged 18-65 years.[36] Another review stated "there is strikingly limited good-quality evidence (all GRADE B, C or not existing) of the effectiveness of influenza vaccination on complications such as pneumonia, hospitalization and influenza-specific and overall mortality."[37] However, a review in 2004 found that "vaccine efficacy were 22% (95% CI = 16-28) for preventing clinically diagnosed cases of influenza and 63% (95% CI = 53-71) for preventing laboratory confirmed cases of influenza."[38] One problem with reports of influenza vaccine effectiveness is selection bias.[39] Who is going to fund and publish a study showing that influenza vaccination is not effective?”One review of ten RCTs found an efficacy of 59% for adults aged 18-65 years.[36] Another review stated "there is strikingly limited good-quality evidence (all GRADE B, C or not existing) of the effectiveness of influenza vaccination on complications such as pneumonia, hospitalization and influenza-specific and overall mortality."[37] However, a review in 2004 found that "vaccine efficacy were 22% (95% CI = 16-28) for preventing clinically diagnosed cases of influenza and 63% (95% CI = 53-71) for preventing laboratory confirmed cases of influenza.".[38] One problem with report of influenza vaccine effectiveness is selection bias.[39] Who is going to fund and publish a study showing that influenza vaccination is not effective?
Orthomolecular Medicine News Service Opinion material
„The CDC recommends at least 50 vaccine shots for babies, children, and teenagers.[9] The Amish do not vaccinate children because of safety concerns (not religious beliefs).”CDC recommends at least 50 vaccine shots to babies, children, and teenagers. [9] The Amish do not vaccinate children because of safety concerns (not religious beliefs).
Orthomolecular Medicine News Service Opinion material
„Cherry AD., 2004 "Determination of Serum Antibody to Bordetella Pertussis Adenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults with Pertussis." Clin Infect Dis. Feb 15;38(4):502-7 8. Cherry JD et. al., 2004. "Determination of Serum Antibody to Bordetella Pertussis Adenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults with Pertussis." Clin Infect Dis. Feb 15;38(4):502-7 PMID 14765342 9. Cherry JD et. al., 2010. "Antibody response patterns to Bordetella Pertussis antigens in vaccinated and unvaccinated young children with Pertussis." Clin. Vac. Immun. May 17(5): 741-747.”Cherry AD., 2004 "Determination of Serum Antibody to Bordetella Pertussis Adenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults with Pertussis." Clin Infect Dis. Feb 15;38(4):502-7 8. Cherry JD et. al., 2004. "Determination of Serum Antibody to Bordetella Pertussis Adenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults with Pertussis." Clin Infect Dis. Feb 15;38(4):502-7 PMID 14765342 9. Cherry JD et. al., 2010. "Antibody response patterns to Bordetella Pertussis antigens in vaccinated and unvaccinated young children with Pertussis."Clin. Vac. Immun. May 17(5): 741-747.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.